Mycophenolate mofetil 500 mg film-coated tablets

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Mycophenolate mofetil is and what it is used for
2. What you need to know before you take Mycophenolate mofetil
3. How to take Mycophenolate mofetil
4. Possible side effects
5. How to store Mycophenolate mofetil
6. Contents of the pack and other information

Mycophenolate causes birth defects and miscarriage. If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor.

Your doctor will speak to you and give you written information, particularly on the effects of mycophenolate on unborn babies. Read the information carefully and follow the instructions.

If you do not fully understand these instructions, please ask your doctor to explain them again before you take mycophenolate. See also further information in this section under “Warnings and Precautions” and “Pregnancy and breast-feeding”

• you are allergic to mycophenolate mofetil, mycophenolic acid or any of the other ingredients in this medicine (listed in section 6),
• you are a woman who could be pregnant and you have not provided a negative pregnancy test before your first prescription as mycophenolate causes birth defects and miscarriage,
• you are pregnant or planning to become pregnant or think you may be pregnant,
• you are not using effective contraception (see Pregnancy, contraception and breast-feeding),
• you are breast-feeding.

Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking mycophenolate mofetil.

Talk to your doctor straight away before taking Mycophenolate mofetil:

• if you are older than 65 years as you may have an increased risk of developing adverse events such as certain viral infections, gastrointestinal bleeding and pulmonary oedema when compared to younger patients,
• if you have a sign of infection such as a fever or sore throat,
• if you have any unexpected bruising or bleeding,
• if you have ever had a problem with your digestive system such as a stomach ulcer,
• if you are planning to become pregnant or if you get pregnant while taking this medicine,
• if you have a hereditary enzyme deficiency such as Lesch-Nyhan and Kelley-Seegmiller syndrome.

If any of the above apply to you (or you are not sure), talk to your doctor straight away before taking Mycophenolate mofetil.

Mycophenolate mofetil reduces your body’s defences. As a result, there is an increased risk of skin cancer. Limit the amount of sunlight and UV light you get. Do this by:

• wearing protective clothing which also covers your head, neck, arms and legs,
• using a sunscreen with a high protection factor.

Do not give this medicine to children younger than 2 years because based on the limited safety and efficacy data for this age group no dose recommendations can be made.

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, such as herbal medicines. This is because Mycophenolate mofetil can affect the way some other medicines work. Also, other medicines can affect the way this medicine works.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines before you start Mycophenolate mofetil.

• azathioprine or other medicines which suppress your immune system – given after a transplant operation.
• cholestyramine – used to treat high cholesterol.
• rifampicin – an antibiotic used to prevent and treat infections such as tuberculosis (TB).
• antacids or proton pump inhibitors – used for acid problems in your stomach such as indigestion.
• phosphate binders – used by people with chronic kidney failure to reduce how much phosphate gets absorbed into their blood.
• antibiotics – used to treat bacterial infections.
• isavuconazole – used to treat fungal infections.
• telmisartan – used to treat high blood pressure.

If you need to have a vaccine (a live vaccine) while taking Mycophenolate mofetil, talk to your doctor or pharmacist first. Your doctor will have to advise you on what vaccines you can have.

You must not donate blood during treatment with Mycophenolate mofetil and for at least 6 weeks after stopping treatment. Men must not donate semen during treatment with this medicine and for at least 90 days after stopping treatment.

Taking food and drink has no effect on your treatment with this medicine.

Contraception in women taking Mycophenolate mofetil

If you are a woman who could become pregnant you must use an effective method of contraception with Mycophenolate mofetil. This includes:

• before you start taking mycophenolate mofetil,
• during your entire treatment with mycophenolate mofetil,
• for 6 weeks after you stop taking mycophenolate mofetil.

Talk to your doctor about the most suitable contraception for you. This will depend on your individual situation. Two forms of contraception are preferable as this will reduce the risk of unintended pregnancy. Contact your doctor as soon as possible, if you think your contraception may not have been effective or if you have forgotten to take your contraceptive pill.

You cannot become pregnant if any of the following conditions applies to you:

• you are post-menopausal, i.e. at least 50 years old and your last period was more than a year ago (if your periods have stopped because you have had treatment for cancer, then there is still a chance you could become pregnant),
• your fallopian tubes and both ovaries have been removed by surgery (bilateral salpingo-oophorectomy),
• your womb (uterus) has been removed by surgery (hysterectomy),
• your ovaries no longer work (premature ovarian failure, which has been confirmed by a specialist gynaecologist),
• you were born with one of the following rare conditions that make pregnancy impossible: the XY genotype, Turner’s syndrome or uterine agenesis,
• You are a child or teenager who has not started having periods.

Contraception in men taking Mycophenolate mofetil

The available evidence dose not indicate an increased risk of malformations or miscarriage if the father takes mycophenolate. However, a risk cannot be completely excluded. As a precaution you or your female partner are recommended to use reliable contraception during treatment and for 90 days after you stop taking mycophenolate mofetil.

If you are planning to have a child, talk to your doctor about the potential risks and alternative therapies.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will talk to you about the risks in case of pregnancy and the alternatives you can take to prevent rejection of your transplant organ if:

• you plan to become pregnant,
• you miss or think you have missed a period, or you have unusual menstrual bleeding, or suspect you are pregnant,
• you have sex without using an effective method of contraception.

If you do become pregnant during the treatment with mycophenolate, you must inform your doctor immediately. However, keep taking mycophenolate mofetil until you see him or her.

Pregnancy

Mycophenolate mofetil causes a very high frequency of miscarriage (50%) and of severe birth defects (23-27%) in the unborn baby. Birth defects which have been reported include anomalies of ears, of eyes, of face (cleft lip/palate), of development of fingers, of heart, oesophagus (tube that connects the throat with the stomach), kidneys and nervous system (for example, spina bifida (where the bones of the spine are not properly developed).Your baby may be affected by one or more of these.

If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor. Your doctor may request more than one test to ensure you are not pregnant before starting treatment.

Breast-feeding

Do not take Mycophenolate mofetil if you are breast-feeding. This is because small amounts of the medicine can pass into the mother’s milk.

Mycophenolate mofetil has a moderate influence on your ability to drive or use any tools or machines. If you feel drowsy, numb or confused, talk to your doctor or nurse and do not drive or use any tools or machines until you feel better.

This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free’.

The amount you take depends on the type of transplant you have had. The usual doses are shown below. Treatment will continue for as long as you need to prevent rejection of your transplant organ.

Kidney transplant

Adults

• the first dose is given within 3 days of the transplant operation.
• the daily dose is 4 tablets (2 g of the medicine) taken as 2 separate doses.
• take 2 tablets in the morning and then 2 tablets in the evening.

Children (aged 2 to 18 years)

• the dose given will vary depending on the size of the child.
• your doctor will decide the most appropriate dose based on your child’s height and weight (body surface area – measured as square metres or “m²”). The recommended dose is 600 mg/m² taken twice a day.

Heart transplant

Adults

• the first dose is given within 5 days of the transplant operation.
• the daily dose is 6 tablets (3 g of the medicine) taken as 2 separate doses.
• take 3 tablets in the morning and then 3 tablets in the evening.

Children

There is no information on the use of Mycophenolate mofetil in children with a heart transplant.

Liver transplant

Adults

• the first dose of oral Mycophenolate mofetil will be given to you at least 4 days after the transplant operation and when you are able to swallow oral medicines.
• the daily dose is 6 tablets (3 g of the medicine) taken as 2 separate doses.
• take 3 tablets in the morning and then 3 tablets in the evening.

Children

There is no information on the use of Mycophenolate mofetil in children with a liver transplant.

• swallow your tablets whole with a glass of water.
• do not break or crush them.

If you take more Mycophenolate mofetil than you should, talk to a doctor or go to a hospital straight away. Also do this if someone else accidentally takes your medicine. Take the medicine pack with you.

If you forget to take your medicine at any time, take it as soon as you remember. Then continue to take it at the usual times. Do not take a double dose to make up for a missed dose.

Do not stop taking mycophenolate mofetil unless your doctor tells you to. If you stop your treatment you may increase the chance of rejection of your transplanted organ.

• you have a sign of infection such as a fever or sore throat,
• you have any unexpected bruising or bleeding,
• you have a rash, swelling of your face, lips, tongue or throat, with difficulty breathing - you may be having a serious allergic reaction to the medicine (such as anaphylaxis, angioeodema).

Some of the more usual problems are diarrhoea, fewer white cells or red cells in your blood, infection and vomiting. Your doctor will do regular blood tests to check for any changes in:

• the number of your blood cells or signs of infections.

Children may be more likely than adults to have some side effects. These include diarrhoea, infections, fewer white cells and fewer red cells in the blood.

Mycophenolate mofetil reduces your body’s defences. This is to stop you rejecting your transplant. As a result, your body will not be as good as normal at fighting infections. This means you may catch more infections than usual. This includes infections of the brain, skin, mouth, stomach and gut, lungs and urinary system.

As can happen in patients taking this type of medicine (immune-suppressants), a very small number of patients on mycophenolate have developed cancer of the lymphoid tissues and skin.

You may get general side effects affecting your body as a whole. These include serious allergic reactions (such as anaphylaxis, angioeodema), fever, feeling very tired, difficulty sleeping, pains (such as stomach, chest, joint or muscle, pain on passing urine), headache, flu symptoms and swelling.

Skin problems such as:

• acne, cold sores, shingles, skin growth, hair loss, rash, itching.

Urinary problems such as:

• blood in the urine

Digestive system and mouth problems such as:

• swelling of the gums and mouth ulcers,
• inflammation of the pancreas, colon or stomach,
• gastroinestinal disorders including bleeding,
• liver disorders,
• diarrhoea, constipation, feeling sick (nausea), indigestion, loss of appetite, flatulence.

Nervous system problems such as:

• feeling dizzy, drowsy or numb,
• tremor, muscle spasms, convulsions,
• feeling anxious or depressed, changes in your mood or thoughts.

Heart and blood vessel problems such as:

• change in blood pressure, unusual heartbeat, widening of blood vessels.

Lung problems such as:

• pneumonia, bronchitis,
• shortness of breath, cough, which can be due to bronchiectasis (a condition in which the lung airways are abnormally dilated) or pulmonary fibrosis (scarring of the lung). Talk to your doctor if you develop a persistent cough or breathlessness,
• sinus problems.

Other problems such as:

• weight loss, gout, high blood sugar, bleeding, bruising.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

• The active substance is mycophenolate mofetil. Each tablet contains 500 mg mycophenolate mofetil.
• The other ingredients are: microcrystalline cellulose, povidone, croscarmellose sodium, talc, magnesium stearate. The tablet coating contains: hypromellose, talc, titanium dioxide (E171), macrogol 400, red iron oxide (E172), black iron oxide (E172) and yellow iron oxide (E172).

Mycophenolate mofetil Tillomed 500 mg Film-coated Tablets are purple coloured, capsule shaped, film-coated tablets plain on both sides.

The tablets are available in PVC-aluminium unit dose blisters in pack sizes of 50, 150 and 250 film-coated tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Manufacturer¹